Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


11.03.2019

1 Am J Surg Pathol
1 Am Surg
1 Artif Cells Nanomed Biotechnol
1 Biochem Biophys Res Commun
1 Biochim Biophys Acta Gen Subj
1 Biofabrication
1 Biomed Pharmacother
3 Biosci Rep
1 BJOG
1 BMC Womens Health
2 Brachytherapy
1 Bull Cancer
1 Cancer Causes Control
1 Cell Rep
1 Chem Commun (Camb)
1 Cleve Clin J Med
1 Clin Case Rep
1 Dose Response
1 EBioMedicine
1 Epigenetics
1 Eur J Surg Oncol
1 Eur Rev Med Pharmacol Sci
1 Exp Cell Res
1 Front Med
1 Gynecol Obstet Invest
1 Gynecol Oncol Rep
1 Health Care Women Int
1 Immunol Lett
2 Indian J Cancer
3 Int J Gynecol Cancer
1 J Ayub Med Coll Abbottabad
1 J Int Med Res
1 J Obstet Gynaecol Res
2 JAMA Oncol
1 Jpn J Clin Oncol
1 Korean J Radiol
1 Med Dosim
1 Med J Malaysia
1 Med Sci Monit
1 Mol Clin Oncol
1 Mol Genet Genomic Med
1 Oncogene
1 Oncol Rep
1 Pathol Res Pract
1 Phytother Res
1 PLoS One
1 Public Health Nurs
1 Rev Bras Ginecol Obstet
2 Sci Rep
1 Semin Radiat Oncol
2 Zhonghua Yu Fang Yi Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Surg Pathol

  1. UMPHRESS B, Sanchez B, Paintal A, Nayar R, et al
    Utility of CK7 Versus p16 as a Prognostic Biomarker in CIN 2.
    Am J Surg Pathol. 2018;42:479-484.
    PubMed     Text format     Abstract available


    Am Surg

  2. TAMBURRINI D, Antinori C, Slotman G
    Recurrent Small Bowel Obstruction Caused by Metastatic Cervical Cancer with Negative PAP Screening.
    Am Surg. 2018;84:e305-e306.
    PubMed     Text format    


    Artif Cells Nanomed Biotechnol

  3. ZHANG L, Liu SK, Song L, Yao HR, et al
    SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.
    Artif Cells Nanomed Biotechnol. 2019;47:556-564.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. LIU Z, Teng L, Gao L, Wang H, et al
    The role of eukaryotic translation initiation factor 5A-1 (eIF5A-1) gene in HPV 16 E6 induces cell growth in human cervical squamous carcinoma cells.
    Biochem Biophys Res Commun. 2018;504:6-12.
    PubMed     Text format     Abstract available


    Biochim Biophys Acta Gen Subj

  5. AYDINLIK S, Dere E, Ulukaya E
    Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
    Biochim Biophys Acta Gen Subj. 2019;1863:903-916.
    PubMed     Text format     Abstract available


    Biofabrication

  6. PANG Y, Mao SS, Yao R, He JY, et al
    TGF-beta induced epithelial-mesenchymal transition in an advanced cervical tumor model by 3D printing.
    Biofabrication. 2018;10:044102.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  7. GONG L, Lei Y, Tan X, Dong Y, et al
    Propranolol selectively inhibits cervical cancer cell growth by suppressing the cGMP/PKG pathway.
    Biomed Pharmacother. 2019;111:1243-1248.
    PubMed     Text format     Abstract available


    Biosci Rep

  8. WANG D, Wang H, Li Y, Li Q, et al
    MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma.
    Biosci Rep. 2018;38.
    PubMed     Text format     Abstract available

  9. HUANG SQ, Zhou ZX, Zheng SL, Liu DD, et al
    Association of variants of miRNA processing genes with cervical precancerous lesion risk in a southern Chinese population.
    Biosci Rep. 2018;38.
    PubMed     Text format     Abstract available

  10. WANG JY, Chen LJ
    The role of microRNAs in the invasion and metastasis of cervical cancer.
    Biosci Rep. 2019 Mar 4. pii: BSR20181377. doi: 10.1042/BSR20181377.
    PubMed     Text format     Abstract available


    BJOG

  11. JOINT R, Chen ZE, Cameron S
    Breast and reproductive cancers in the transgender population: a systematic review.
    BJOG. 2018;125:1505-1512.
    PubMed     Text format     Abstract available


    BMC Womens Health

  12. HE J, He L
    Knowledge of HPV and acceptability of HPV vaccine among women in western China: a cross-sectional survey.
    BMC Womens Health. 2018;18:130.
    PubMed     Text format     Abstract available


    Brachytherapy

  13. HARKENRIDER MM, Patel R, Surucu M, Chinsky B, et al
    Can MRI-only replace MRI-CT planning with a titanium tandem and ovoid applicator?
    Brachytherapy. 2018;17:747-752.
    PubMed     Text format     Abstract available

  14. SETHI R, Kuo YC, Edraki B, Lerner D, et al
    Real-time Doppler ultrasound to identify vessels and guide needle placement for gynecologic interstitial brachytherapy.
    Brachytherapy. 2018;17:742-746.
    PubMed     Text format     Abstract available


    Bull Cancer

  15. MARI R, Lambaudie E, Provansal M, Sabatier R, et al
    [Circulating tumor DNA assessment for gynaecological cancers management].
    Bull Cancer. 2019;106:237-252.
    PubMed     Text format     Abstract available


    Cancer Causes Control

  16. THOMPSON B, Barrington WE, Briant KJ, Kupay E, et al
    Educating Latinas about cervical cancer and HPV: a pilot randomized study.
    Cancer Causes Control. 2019 Mar 4. pii: 10.1007/s10552-019-01150.
    PubMed     Text format     Abstract available


    Cell Rep

  17. HE C, Lv X, Huang C, Angeletti PC, et al
    A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis.
    Cell Rep. 2019;26:2636-2650.
    PubMed     Text format     Abstract available


    Chem Commun (Camb)

  18. CHEN F, Yang D, Shen H, Deng M, et al
    Hydrothermal synthesis of novel rhombic dodecahedral SnS nanocrystals for highly efficient photothermal therapy.
    Chem Commun (Camb). 2019;55:2789-2792.
    PubMed     Text format     Abstract available


    Cleve Clin J Med

  19. ZHANG S, Batur P
    Human papillomavirus in 2019: An update on cervical cancer prevention and screening guidelines.
    Cleve Clin J Med. 2019;86:173-178.
    PubMed     Text format     Abstract available


    Clin Case Rep

  20. MIYOSHI A, Kuritani Y, Kanao S, Naoi H, et al
    Aggressive skeletal muscle metastasis from cervical cancer invading into the spinal canal: A case report.
    Clin Case Rep. 2019;7:361-365.
    PubMed     Text format     Abstract available


    Dose Response

  21. WANG WJ, Li Y, Zhu J, Gao MJ, et al
    Prognostic Values of Systemic Inflammation Response (SIR) Parameters in Resectable Cervical Cancer.
    Dose Response. 2019;17:1559325819829543.
    PubMed     Text format     Abstract available


    EBioMedicine

  22. ZHANG Y, Li T, Zhang L, Shangguan F, et al
    Targeting the functional interplay between endoplasmic reticulum oxidoreductin-1alpha and protein disulfide isomerase suppresses the progression of cervical cancer.
    EBioMedicine. 2019 Feb 27. pii: S2352-3964(19)30119.
    PubMed     Text format     Abstract available


    Epigenetics

  23. VERLAAT W, Van Leeuwen RW, Novianti PW, Schuuring E, et al
    Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer.
    Epigenetics. 2018;13:769-778.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  24. MATSUO K, Shimada M, Nakamura K, Takei Y, et al
    Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.
    Eur J Surg Oncol. 2019 Feb 18. pii: S0748-7983(19)30290.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  25. LI FH, Xiang L, Ran L, Zhou S, et al
    BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2019;23:1397-1407.
    PubMed     Text format     Abstract available


    Exp Cell Res

  26. ZOU C, Fan J, He M, Xu Y, et al
    Epigenetic silencing of Rab39a promotes epithelial to mesenchymal transition of cervical cancer through AKT signaling.
    Exp Cell Res. 2019 Feb 28. pii: S0014-4827(18)30776.
    PubMed     Text format     Abstract available


    Front Med

  27. WANG Y, Li G
    PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives.
    Front Med. 2019 Mar 2. pii: 10.1007/s11684-018-0674.
    PubMed     Text format     Abstract available


    Gynecol Obstet Invest

  28. GONZALEZ-BENITEZ C, Salas P, Grabowski JP, Hernandez A, et al
    Lack of Survival Benefit of Para-Aortic Lymphadenectomy in Advanced Cervical Cancer.
    Gynecol Obstet Invest. 2019 Mar 7:1-5. doi: 10.1159/000497350.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  29. SHEN W, Huang Y, Zhou Y, Chang B, et al
    Intestinal metastasis after total laparoscopic radical trachelectomy for stage IB1 cervical cancer: A case report.
    Gynecol Oncol Rep. 2019;28:37-40.
    PubMed     Text format     Abstract available


    Health Care Women Int

  30. COVAN EK
    Cancer.
    Health Care Women Int. 2018;39:505-506.
    PubMed     Text format    


    Immunol Lett

  31. SKARE TL, Neppel A, Machoski MCC, Maestri CA, et al
    ANTINUCLEAR ANTIBODIES IN PATIENTS WITH CERVICAL LESIONS AND INVASIVE CERVICAL CANCER.
    Immunol Lett. 2019 Mar 5. pii: S0165-2478(19)30051.
    PubMed     Text format     Abstract available


    Indian J Cancer

  32. DEVARAPALLI P, Labani S, Nagarjuna N, Panchal P, et al
    Barriers affecting uptake of cervical cancer screening in low and middle income countries: A systematic review.
    Indian J Cancer. 2018;55:318-326.
    PubMed     Text format     Abstract available

  33. MOHANTY SK, Chopra S, Mudaliar A, Kannan S, et al
    A comparative analysis of quality of life after postoperative intensity-modulated radiotherapy or three-dimensional conformal radiotherapy for cervical cancer.
    Indian J Cancer. 2018;55:327-335.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  34. RAZ Y, Keinan-Boker L, Goren S, Soen-Grisaru G, et al
    The effect of age at immigration on cervical cancer incidence: a population-based cohort study of 1 486 438 Israeli women.
    Int J Gynecol Cancer. 2019;29:492-496.
    PubMed     Text format     Abstract available

  35. GUANI B, Dorez M, Magaud L, Buenerd A, et al
    Impact of micrometastasis or isolated tumor cells on recurrence and survival in patients with early cervical cancer: SENTICOL Trial.
    Int J Gynecol Cancer. 2019;29:447-452.
    PubMed     Text format     Abstract available

  36. MABUCHI S, Yokoi E, Shimura K, Komura N, et al
    A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy.
    Int J Gynecol Cancer. 2019;29:474-479.
    PubMed     Text format     Abstract available


    J Ayub Med Coll Abbottabad

  37. ARA C, Inayat K, Hanif A, Afsar S, et al
    A Study Of Agreement Between Visual Inspection With Acetic Acid Of Cervix And Pap Smear For Cervical Cancer Screening.
    J Ayub Med Coll Abbottabad. 2018;30.
    PubMed     Text format     Abstract available


    J Int Med Res

  38. KORKUT Y
    Assessment of knowledge, attitudes, and behaviors regarding breast and cervical cancer among women in western Turkey.
    J Int Med Res. 2019 Mar 7:300060519830252. doi: 10.1177/0300060519830252.
    PubMed     Text format     Abstract available


    J Obstet Gynaecol Res

  39. YAGI A, Ueda Y, Nakagawa S, Morimoto A, et al
    Relation between the number of board-certified gynecologic oncologists per hospital and survival of cervical cancer.
    J Obstet Gynaecol Res. 2019 Mar 6. doi: 10.1111/jog.13948.
    PubMed     Text format     Abstract available


    JAMA Oncol

  40. WANG Y, VanderWalde N, Ballo MT
    Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer-In Reply.
    JAMA Oncol. 2019 Mar 7. pii: 2727349. doi: 10.1001/jamaoncol.2019.0028.
    PubMed     Text format    

  41. SCHERNBERG A, Haie-Meder C, Chargari C
    Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer.
    JAMA Oncol. 2019 Mar 7. pii: 2727346. doi: 10.1001/jamaoncol.2018.5096.
    PubMed     Text format    


    Jpn J Clin Oncol

  42. DRACHAM CB, Mahajan R, Rai B, Elangovan A, et al
    Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma.
    Jpn J Clin Oncol. 2019;49:146-152.
    PubMed     Text format     Abstract available


    Korean J Radiol

  43. ENGELAERE C, Poncelet E, Durot C, Dohan A, et al
    Pelvic MRI: Is Endovaginal or Rectal Filling Needed?
    Korean J Radiol. 2018;19:397-409.
    PubMed     Text format     Abstract available


    Med Dosim

  44. TSAI YL, Yu PC, Nien HH, Sung SY, et al
    Radiation Dose in the Uterine Perforation by Tandem in 3-Dimensional Cervical Cancer Brachytherapy.
    Med Dosim. 2019 Mar 4. pii: S0958-3947(19)30024.
    PubMed     Text format     Abstract available


    Med J Malaysia

  45. ROMLI R, Shahabudin S, Saddki N, Mokhtar N, et al
    Cervical cancer and pap smear screening: knowledge, attitude and practice among working women in northern state of Malaysia.
    Med J Malaysia. 2019;74:8-14.
    PubMed     Text format     Abstract available


    Med Sci Monit

  46. YIN X, Zhu L, Tan W, Zhu X, et al
    Time Intervals Between Prior Cervical Conization and Posterior Hysterectomy Influence Postoperative Infection in Patients with Cervical Intraepithelial Neoplasia or Cancer.
    Med Sci Monit. 2018;24:9063-9072.
    PubMed     Text format     Abstract available


    Mol Clin Oncol

  47. MABUCHI Y, Takiguchi Y, Yahata T, Mizoguchi M, et al
    Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer.
    Mol Clin Oncol. 2019;10:382-386.
    PubMed     Text format     Abstract available


    Mol Genet Genomic Med

  48. AIERKEN K, Dong Z, Abulimiti T, Zhang Y, et al
    CDK6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.
    Mol Genet Genomic Med. 2019 Mar 4:e626. doi: 10.1002.
    PubMed     Text format     Abstract available


    Oncogene

  49. ZHOU CF, Ma J, Huang L, Yi HY, et al
    Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1.
    Oncogene. 2019;38:1256-1268.
    PubMed     Text format     Abstract available


    Oncol Rep

  50. ZHENG M, Zhou Q, Liu X, Wang C, et al
    CTHRC1 overexpression promotes cervical carcinoma progression by activating the Wnt/PCP signaling pathway.
    Oncol Rep. 2019;41:1531-1538.
    PubMed     Text format     Abstract available


    Pathol Res Pract

  51. CHEN B, Jiao Y, Yaolong F, Li T, et al
    The POLR2E rs3787016 polymorphism is strongly associated with the risk of female breast and cervical cancer.
    Pathol Res Pract. 2019 Feb 27. pii: S0344-0338(18)31776.
    PubMed     Text format     Abstract available


    Phytother Res

  52. ROY R, Pal D, Sur S, Mandal S, et al
    Pongapin and Karanjin, furanoflavanoids of Pongamia pinnata, induce G2/M arrest and apoptosis in cervical cancer cells by differential reactive oxygen species modulation, DNA damage, and nuclear factor kappa-light-chain-enhancer of activated B cell si
    Phytother Res. 2019 Mar 5. doi: 10.1002/ptr.6302.
    PubMed     Text format     Abstract available


    PLoS One

  53. SILVEIRA CRF, Cipelli M, Manzine C, Rabelo-Santos SH, et al
    Swainsonine, an alpha-mannosidase inhibitor, may worsen cervical cancer progression through the increase in myeloid derived suppressor cells population.
    PLoS One. 2019;14:e0213184.
    PubMed     Text format     Abstract available


    Public Health Nurs

  54. WILLIAMS LB, McCall A, Looney SW, Joshua T, et al
    Demographic, psychosocial, and behavioral associations with cancer screening among a homeless population.
    Public Health Nurs. 2018;35:281-290.
    PubMed     Text format     Abstract available


    Rev Bras Ginecol Obstet

  55. DOS SANTOS LN, Castaneda L, de Aguiar SS, Thuler LCS, et al
    Health-related Quality of Life in Women with Cervical Cancer.
    Rev Bras Ginecol Obstet. 2019 Mar 7. doi: 10.1055/s-0039-1683355.
    PubMed     Text format     Abstract available


    Sci Rep

  56. BARR JA, Hayes KE, Brownmiller T, Harold AD, et al
    Long non-coding RNA FAM83H-AS1 is regulated by human papillomavirus 16 E6 independently of p53 in cervical cancer cells.
    Sci Rep. 2019;9:3662.
    PubMed     Text format     Abstract available

  57. HUANG H, Liu Q, Zhu L, Zhang Y, et al
    Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients with Cervical Cancer.
    Sci Rep. 2019;9:3284.
    PubMed     Text format     Abstract available


    Semin Radiat Oncol

  58. JURGENLIEMK-SCHULZ IM, Beriwal S, de Leeuw AAC, Lindegaard JC, et al
    Management of Nodal Disease in Advanced Cervical Cancer.
    Semin Radiat Oncol. 2019;29:158-165.
    PubMed     Text format     Abstract available


    Zhonghua Yu Fang Yi Xue Za Zhi

  59. ZHANG SK, Zhao DM, Chen HM, Guo Z, et al
    [The clinical performance of high risk HPV DNA test among triage women with cytology showing atypical squamous cells of undetermined significance].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2018;52:941-945.
    PubMed     Text format     Abstract available

  60. ZHAO J
    [Role of obstetricians and gynecologists in cervical cancer screening].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:241-246.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: